Friday, July 17, 2026
Tuesday, July 7, 2026
LRTI: Discharge Criteria and Continued stay criteria
🏥 LRTI - Discharge Criteria & Continued Stay Criteria
Lower Respiratory Tract Infection Management Decision Points
✅ Criteria for Safe Hospital Discharge
Patients should meet ALL criteria before discharge is considered safe and appropriate.
Clinical Stability Criteria
- Temperature: ≤ 37.5°C (99.5°F) for ≥24 hours without antipyretics
- Heart Rate: 60-100 bpm (or baseline rate if known)
- Respiratory Rate: 12-20 breaths/minute
- Blood Pressure: Systolic ≥90 mmHg, Diastolic ≥60 mmHg (no vasopressors)
- SpO₂: ≥92% on room air (or baseline for COPD patients)
- Alert & Oriented: Normal mental status (no confusion/delirium)
- No Respiratory Distress: No tachypnea, stridor, or use of accessory muscles
- Adequate Oxygenation: pO₂ ≥60 mmHg on room air (or stable baseline)
- No Hypercapnia: pCO₂ normal range or chronic baseline
- Effective Cough: Able to expectorate secretions
- No Supplemental O₂ Requirement: Or minimal requirement (<2-3 L/min)
- Adequate Oral Intake: Able to eat and drink without difficulty
- No Dysphagia: No aspiration risk, normal swallowing
- Tolerating Oral Medications: No IV medications required
- Nausea/Vomiting Controlled: Not requiring IV antiemetics
- Bowel Function Intact: Regular bowel movements
Infectious Disease Criteria
- WBC Count: ≤11,000/μL (normalized or trending down)
- CRP/Procalcitonin: Normalized or significantly decreased
- Blood Cultures: Negative (if initially positive)
- Sputum Culture: No new pathogenic organisms identified
- No Fever: Afebrile for ≥24-48 hours
- Antibiotic Course: Completed appropriate duration (7-10 days for CAP)
📋 Discharge Readiness Checklist
⛔ Criteria for Continued Hospitalization
Patients meeting ANY of these criteria should NOT be discharged.
Clinical Instability - RED FLAGS
- Persistent Fever: Temperature >38°C despite antibiotics (>48-72 hours)
- Tachycardia: HR >120 bpm persistently
- Tachypnea: RR >24 breaths/minute or acute worsening
- Hypotension: SBP <90 mmHg requiring vasopressor support
- Hypoxemia: SpO₂ <90% on room air, requiring supplemental O₂
- Altered Mental Status: Confusion, delirium, decreased LOC
- Respiratory Distress: Use of accessory muscles, stridor, grunting
- Hypoxemia: pO₂ <60 mmHg despite supplemental oxygen
- Hypercapnia: pCO₂ >50 mmHg with respiratory acidosis
- Need for Mechanical Ventilation: Current intubation or impending need
Infectious Disease Criteria - RED FLAGS
- Positive Blood Cultures: Bacteremia present, requires investigation
- Persistent WBC Elevation: WBC >15,000/μL with left shift
- Rising CRP/Procalcitonin: Increasing inflammatory markers despite therapy
- Resistant Organisms: MRSA, MDR gram-negatives, fungal agents
- Treatment Failure: No improvement by 48-72 hours on antibiotics
⛔ Continued Stay RED FLAG Checklist
📋 Clinical Assessment Tools
CURB-65 Score at Discharge Assessment
| CURB-65 Score | Discharge Readiness | Action |
|---|---|---|
| 0-1 (Low Risk) | Excellent candidate for discharge | Discharge with outpatient follow-up; oral antibiotics |
| 2 (Intermediate) | Safe to discharge if clinically stable | Monitor 24 hours; transition to oral meds |
| ≥3 (High Risk) | Requires continued hospitalization | Do NOT discharge; continue IV antibiotics |
PSI (Pneumonia Severity Index) - Risk Stratification
| PSI Class | Mortality | Discharge Recommendation |
|---|---|---|
| Class I | <0.1% | ✅ Safe outpatient management |
| Class II | 0.6% | ✅ Consider discharge after observation |
| Class III | 0.9-1.3% | ⚠️ Brief hospitalization required |
| Class IV | 6.8-8.2% | ❌ Hospitalization required |
| Class V | 27-31% | ❌ ICU-level care required |
📞 Discharge & Follow-up Care Planning
Follow-up Schedule
| Timeframe | Action/Assessment | By Whom |
|---|---|---|
| 24-48 hours | Telephone check-in; confirm medication compliance | Nurse or PCP |
| 1 week | In-person PCP visit; assess treatment response | Primary Care Physician |
| 4 weeks | Assess symptom resolution; repeat labs if needed | Primary Care Physician |
| 1-3 months | Repeat CXR if immunocompromised or prolonged symptoms | PCP or Pulmonology |
- Return fever (>38.5°C)
- Worsening shortness of breath
- Chest pain or hemoptysis
- Mental status changes
- Severe fatigue or syncope
LRTI DIAGNOSIS

PRCS (Protected Respiratory Catheter Specimen) - Protected Specimen Brush:
- Bronchoscopic technique with direct visualization
- Protected catheter design prevents upper airway contamination
- Quantitative culture: ≥10³-10⁴ CFU/mL diagnostic for VAP
- Higher specificity (~90%) but more invasive
- Requires expertise and equipment
Extation (Endotracheal Aspiration):
- Simple blind bedside procedure with suction catheter
- No visualization needed
- Higher diagnostic threshold: ≥10⁴-10⁵ CFU/mL
- Higher sensitivity (~70-90%) but lower specificity (~60%)
- Cost-effective and readily available 24/7

Sunday, July 5, 2026
Acute Kidney Injury
AKI Management Algorithm (Step-by-Step)
Step 1: Diagnose AKI
- Criteria:
- SCr increase ≥0.3 mg/dL within 48h or ≥1.5× baseline.
- Urine output <0.5 mL/kg/h for ≥6h.
- Rule out pseudorenal failure (e.g., dehydration, obstruction).
Step 2: Stage AKI (KDIGO)
|
Stage |
SCr Criteria |
Urine Output Criteria |
|
1 |
≥0.3 mg/dL or 1.5–1.9× baseline |
<0.5 mL/kg/h for 6–12h |
|
2 |
2.0–2.9× baseline |
<0.5 mL/kg/h for ≥12h |
|
3 |
≥3.0× baseline or ≥4.0 mg/dL |
<0.3 mL/kg/h for ≥24h or anuria |
Step 3: Identify the Cause
Prerenal (60%)
- History/Exam: Hypotension, dehydration, heart failure.
- Labs: FeNa <1%, urine osmolality >500 mOsm/kg.
- Management: Fluid resuscitation, optimize hemodynamics.
Intrinsic (35%)
- ATN: Acute Tubular Necrosis: Ischemia, toxins (aminoglycosides, contrast).
- Labs: FeNa >2%, granular casts.
- Management: Discontinue nephrotoxins, supportive care.
- AIN: Acute interstitial nephritis: Drugs (penicillin, PPIs, NSAIDs).
- Labs: Eosinophils in urine, rash, fever.
- Management: Stop offending drugs, ± steroids.
- Glomerulonephritis/Vasculitis:
- Labs: Proteinuria, hematuria, low C3/C4.
- Management: Immunosuppression (steroids, cyclophosphamide).
Postrenal (5%)
- History/Exam: Obstruction (stones, BPH, tumors).
- Imaging: Renal ultrasound (hydronephrosis).
- Management: Catheterization, nephrostomy, or stenting.
Step 4: Immediate Management
- For All AKI:
- Discontinue nephrotoxins (NSAIDs, ACEi/ARBs, aminoglycosides).
- Optimize hemodynamics (fluids, vasopressors if needed).
- Monitor:
- SCr, BUN, electrolytes (K⁺, Na⁺, Ca²⁺, PO₄³⁻).
- Urine output (Foley catheter if oliguric).
- Fluid balance (strict I/O).
- Correct Electrolyte Imbalances:
- Hyperkalemia (K⁺ >6.5 mEq/L):
- Calcium gluconate (10 mL IV over 10 min).
- Insulin + glucose (10 units insulin + 50 mL D50).
- Albuterol nebulization (10–20 mg).
- Dialysis if refractory or ECG changes.
- Metabolic acidosis (pH <7.1): Bicarbonate.
- Fluid overload: Diuretics (if responsive) or RRT.
Step 5: Indications for RRT (Dialysis)
Start RRT if AEIOU criteria are met:
- Acidosis (pH <7.1, refractory).
- Electrolyte disturbances (K⁺ >6.5 mEq/L, refractory).
- Intoxication (dialyzable toxins: lithium, methanol, ethylene glycol).
- Overload (fluid overload refractory to diuretics).
- Uremia (BUN >100 mg/dL, pericarditis, encephalopathy, bleeding).
Modality Choice:
- Intermittent Hemodialysis (IHD): Stable patients.
- Continuous RRT (CRRT): Hemodynamically unstable (ICU).
- Peritoneal Dialysis (PD): If vascular access is difficult.
Step 6: Supportive Care
- Nutrition:
- Protein: 0.8–1.0 g/kg/day.
- Calories: 25–30 kcal/kg/day.
- Fluid Balance:
- Restrict fluids if oliguric (insensible losses + urine output).
- Infection Prophylaxis:
- Adjust antibiotic doses for renal function.
Step 7: Monitor and Follow-Up
- Daily:
- SCr, BUN, electrolytes, urine output, weight, fluid balance.
- Renal Ultrasound: If no improvement in 24–48h (rule out obstruction).
- Nephrology Consult:
- Stage 2–3 AKI.
- Unclear etiology.
- Need for RRT.
Step 8: Prognosis and Prevention
- Prognosis:
- Mortality: ~10–30% (higher in ICU, sepsis, Stage 3).
- Recovery: Prerenal AKI often reversible; ATN may take weeks.
- ~20–30% progress to CKD.
- Prevention:
- Avoid nephrotoxins.
- Hydrate before contrast procedures.
- Optimize hemodynamics in high-risk patients.
Quick Reference Table: AKI Causes and Management
|
Type |
Causes |
Diagnostic Clues |
Management |
|
Pre-renal |
Hypovolemia, hypotension, HF |
FeNa <1%, urine osmolality >500 |
Fluids, optimize hemodynamics |
|
ATN |
Ischemia, toxins (aminoglycosides) |
FeNa >2%, granular casts |
Discontinue nephrotoxins, supportive |
|
AIN |
Drugs (penicillin, PPIs, NSAIDs) |
Eosinophils in urine, rash, fever |
Stop drug, ± steroids |
|
Glomerulonephritis |
Immune-mediated (e.g., vasculitis) |
Proteinuria, hematuria, low C3/C4 |
Immunosuppression (steroids, cyclophosphamide) |
|
Post-renal |
Obstruction (stones, BPH, tumors) |
Hydronephrosis on ultrasound |
Catheterization, nephrostomy, stenting |
